Hoffmann, L., Persson, G., Nygård, L., Nielsen, T., Borrisova, S., Gaard-Petersen, F., Josipovic, M., Khalil, A., Kjeldsen, R., Knap, M., Kristiansen, C., Møller, D., Ottosson, W., Sand, H., Thing, R., Pøhl, M., & Schytte, T. (2022). thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours. Radiotherapy and oncology, 171, 53–61. http://access.bl.uk/ark:/81055/vdc_100156441472.0x000041